NCT06549036Not yet recruiting
Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
Randomized Trial of Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The project will investigate the efficacy of a Veteran-peer-navigator-led decision coaching (PDC) program to promote Shared Decision Making (SDM) for prostate cancer screening among Veterans at the Veterans Health Administration (VA). Prostate cancer is commonly screen detected using PSA, a non-specific test which has led to modest population-level survival benefits at the cost of over-detection of low-risk disease. This trade off in outcomes is ideally addressed using SDM which can be challenging to implement in time constrained primary care office visits. The investigators propose the evaluation of a PDC intervention to promote SDM for PSA screening to improve both access and quality of care for Veterans. The investigators results will enhance understanding of the efficacy, cost-effectiveness, and sustainability of PDC interventions for SDM promotion across communication formats in the VA. Lessons learned through this proposal will not only improve quality of care for PSA screening but also will suggest a paradigm for dissemination of SDM across preventive services.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 228 (estimated)
- First submitted
- 8 Aug 2024
- Start date
- 4 Jan 2027
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- VA Office of Research and Development
- Diseases
- Prostate cancer
- NCT number
- NCT06549036
What you commit to
- Study type: Interventional
- Planned participants: 228
- From 4 Jan 2027 to the primary completion date, 1 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a prior diagnosis of prostate cancer (ICD-10-CM C61)
Other illness
- Patients seen within 180 days after primary diagnosis of urinary obstruction, prostatitis, hematuria, other disorder of prostate, unexplained weight loss, or lumbar back pain
Other
- Veteran Patients:
- Patients seen within 9 months of other prostate-specific antigen (PSA) tests
- Patients visiting their provider for any indication other than a well-visit appointment
- Providers:
- \- Providers who do not treat adult male patients (e.g. OB/Gyns, pediatricians)
Who the study is looking for
- Veteran patient participants:
- Veteran
- Male
- Attending VANYHHS-Manhattan for routine primary care appointment
- Providers:
- Primary care provider at VA New York Harbor Healthcare System (VANYHHS)
- Caring for patients that fit inclusion criteria
Age in the registry: 40 years to 69 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| VA NY Harbor Healthcare System, New York, NY Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.